Hans‐Georg Eichler

Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?

Hans‐Georg Eichler, Sheldon X. Kong, William C. Gerth et al. · Value in Health · 2004 · 803 citations · Full text

Pharmacy, Economics, Pharmacoeconomics +15

Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making

Marc L. Berger, Harold C. Sox, Richard J. Willke et al. · Value in Health · 2017 · 452 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +17

Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint <scp>ISPOR‐ISPE</scp> Special Task Force on real‐world evidence in health care decision making

Marc L. Berger, Harold C. Sox, Richard J. Willke et al. · Pharmacoepidemiology and Drug Safety · 2017 · 344 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +17

Asthma severity and medical resource utilisation

Leonardo Antonicelli, C. Bucca, Margherita Neri et al. · European Respiratory Journal · 2004 · 294 citations · Full text

Pharmacy, Internal Medicine, Health Economics +16

Should 5-Hydroxytryptamine-3 Receptor Antagonists Be Administered Beyond 24 Hours After Chemotherapy to Prevent Delayed Emesis? Systematic Re-Evaluation of Clinical Evidence and Drug Cost Implications

Olga Geling, Hans‐Georg Eichler · Journal of Clinical Oncology · 2005 · 267 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17